Spiro-pentacyclic compounds

Details Spiro-pentacyclic compounds Spiro-pentacyclic compounds

2006-12-05

2006-12-05

Owens, Amelia A. (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S232500, C544S070000, C544S153000, C546S015000, C546S197000

Reexamination Certificate

active

07144890

ABSTRACT:
The present invention relates to compounds of the formula (I)and pharmaceutically acceptable salts thereof, for use as therapeutically active substances. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with the modulation of CB1 receptors including obesity.

REFERENCES:
patent: 3940418 (1976-02-01), Hamilton
patent: 5462960 (1995-10-01), Barth et al.
patent: 5596106 (1997-01-01), Cullinan et al.
patent: 5624941 (1997-04-01), Barth et al.
patent: 6355631 (2002-03-01), Achard et al.
patent: 6479479 (2002-11-01), Achard et al.
patent: 6518264 (2003-02-01), Achard et al.
patent: 6566356 (2003-05-01), Achard et al.
patent: 6734176 (2004-05-01), Achard et al.
patent: 2001/0027193 (2001-10-01), Achard et al.
patent: 2002/0019383 (2002-02-01), Achard et al.
patent: 2002/0035102 (2002-03-01), Achard et al.
patent: 2003/0055033 (2003-03-01), Achard et al.
patent: 2003/0119810 (2003-06-01), Achard et al.
patent: 2003/0162808 (2003-08-01), Achard et al.
patent: 2004/0157823 (2004-08-01), Achard et al.
patent: 2004/0235816 (2004-11-01), Achard et al.
patent: 565354 (1993-10-01), None
patent: 576357 (1993-12-01), None
patent: 658546 (2001-05-01), None
patent: 2783246 (2000-03-01), None
patent: 2805810 (2001-09-01), None
patent: 2805817 (2001-09-01), None
patent: 2805818 (2001-09-01), None
patent: WO9602248 (1996-02-01), None
patent: WO9719063 (1997-05-01), None
patent: WO0015609 (2000-03-01), None
patent: WO0046209 (2000-08-01), None
patent: WO0132663 (2001-05-01), None
patent: WO0164632 (2001-09-01), None
patent: WO0164633 (2001-09-01), None
patent: WO0164634 (2001-09-01), None
patent: WO0170700 (2001-09-01), None
patent: WO0228346 (2002-04-01), None
patent: WO02076949 (2002-10-01), None
patent: WO03020217 (2003-03-01), None
patent: WO0335005 (2003-05-01), None
patent: WO0337332 (2003-05-01), None
patent: WO03040107 (2003-05-01), None
patent: WO03051850 (2003-06-01), None
patent: WO03063781 (2003-08-01), None
patent: WO03077847 (2003-09-01), None
patent: WO03078413 (2003-09-01), None
patent: WO03082190 (2003-10-01), None
patent: WO03082833 (2003-10-01), None
patent: WO03084930 (2003-10-01), None
patent: WO03084943 (2003-10-01), None
patent: WO03086288 (2003-10-01), None
patent: WO03087037 (2003-10-01), None
patent: WO 2004/013120 (2004-02-01), None
D. Shire, et. al., J. Biol. Chem. 270 (8) (1995) 3726-31.
S. Munro, et. al., Nature 365 (1993) 61-61.
Y. Gaoni, et. al., J. Am. Chem. Soc., 86 (1964) 1646.
R. Mechoulam (Ed) “Cannabinoids as Therapeutic Agents” (1986) 1-20, CRC Press.
R.G. Pertwee, Pharmaceut. Sci. 3 (11) (1997) 539-545.
E.M. Williamson, et. al., Drugs 60 (6) (2000) 1303-1314.
R.G. Pertwee, Curr Med Chem, 6 (8) (1999) 635-664.
W.A. Devane, et. al., Science 258 (1992) 1946-9.
V. Di Marzo, et. al., Trends in Neuroscience 21 (12) (1998) 521-528.
A.C. Porter, et. al., Pharmacol. Ther., 90 (1) (2001) 45-60.
C.M. Williams, Psychopharmacology 143 (3) (1999) 315-317.
C.C. Felder, et. al., Proc. Natl. Acad. Sci. USA 90 (16) (1993) 7656-60.
G. Colombo, et. al., Life Sci. 63 (8) (1998) L113-PL117.
V. Di Marzo, et. al., Nature 410 (6830) 822-825.
F. Barth, et. al., “Cannabinoid Antagonists:From research tools to potential new drugs”, Abstracts of Papers, 222ndACS National Meeting, Chicago, IL Aug. 26-30, 2001.
AAI; M. Pacheco, et. al., J. Pharmacol. Exp. Ther. 257 (1) (1991) 170-183.
WIN54661; F. M. Casiano, et. al., NIDA Res. Monogr. 105 (1991) 295-6.
AM630; K. Hosohata, et. al., Life Sci. 61 (1997) 115-118.
R. Pertwee, et. al., Life Sci. 56 (23-24) (1995) 1949-55.
LY320135, C.C.Felder, et. al., J. Pharmacol Exp Ther 284 (1) (1998) 291-7.
M. Kanyonyo, et. al., Bioorg. Med. Chem. Lett 9 (15) (1999) 2233-2236.
F. Ooms, et. al., J. Med. Chem 45 (9) (2002) 1748-1756.
J.M. Mussinu, et. al., Bioorg Med Chem (2003) 11, 251.
S. Ruiu, et. al., J. Pharm. Expt. Ther. (2003) 306, 363.
G. Tarzia, et. al., Bioorg. Med. Chem. (2003), 11, 3965.

Affiliated with

Also associated with

Rating

Spiro-pentacyclic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Spiro-pentacyclic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spiro-pentacyclic compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3718314